DBV Technologies SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Okay. Great. Let's go ahead and get started. Welcome, everyone. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. And happy to have with me today, Daniel Tassé, CEO of DBV Technologies. Daniel, thank you for joining us.
©,-&
Thanks for having me, and good morning, good afternoon to everyone.
Great. And before we go ahead and get started, let me read a quick disclosure from our side. Please note that this webcast is from Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley Research Disclosure Website at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |